abstract |
A combination, comprising N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4- [ 1,3,4- oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide, or a pharmaceutically acceptable salt thereof, and pemetrexed, or a pharmaceutically acceptable salt thereof is described. The combination is expected to be beneficial in the treatment of cancer, particularly lung cancer. |